Investor Summary
Fund Strategy
FUND PERFORMANCE AS OF 31st March 2026
| ANNUALIZED SINCE INCEPTION | QUARTERLY | YTD |
|---|---|---|
| - | - | - |
| ANNUALIZED SINCE INCEPTION | QUARTERLY | YTD |
|---|---|---|
| - | - | - |
ClearBridge Large Cap Growth Strategy outperformed its benchmark during a challenging first quarter 2026 marked by geopolitical tensions and AI-driven software selloffs. The strategy benefited from diversified exposure beyond mega-cap technology, with materials and industrials leading contributions through holdings like Linde, Sherwin-Williams, and Eaton. The managers actively repositioned the portfolio, adding Texas Instruments in semiconductors and Roche and Alnylam in biotechnology while exiting underperforming software names including Salesforce and PayPal. Key risks include ongoing geopolitical tensions from Middle East conflict, rising bond yields from oil price inflation, and continued AI disruption fears affecting software valuations. The team remains optimistic about early-cycle industrial momentum and semiconductor recovery, though acknowledges some erosion due to conflict. Portfolio implications include continued risk management through trimming strong performers and upgrading quality in semiconductors and biotech. The strategy demonstrated the efficacy of diversified growth investing during a risk-off environment that rewarded quality fundamentals over momentum.
ClearBridge Large Cap Growth Strategy focuses on diversified growth investing beyond mega-cap technology, emphasizing quality fundamentals and active risk management while positioning for cyclical recovery in industrials and selective opportunities in semiconductors and biotechnology.
The managers believe the start of 2026 demonstrated stabilization for the Strategy compared to the prior year. They remain optimistic that pent-up activity in the manufacturing economy can be supportive of portfolio results, despite some erosion in early-cycle momentum due to geopolitical conflict.
| Date | Letter | Tickers | Keywords | Pitches | Quick Takes |
|---|---|---|---|---|---|
| Apr 8 2026 | 2026 Q1 | ALNY, ASML, BX, COST, CRM, EQIX, ETN, FICO, GWW, INTU, LIN, MSFT, NFLX, ORCL, PYPL, RHHBY, RTX, SHW, TSM, TXN | AI, Biotechnology, defense, growth, industrials, large cap, semiconductors, technology |
TXN ROG.SW ALNY CRM PYPL |
ClearBridge Large Cap Growth outperformed during Q1 2026's geopolitical volatility by diversifying beyond mega-cap tech into quality industrials and materials. Active repositioning added semiconductor and biotech exposure while exiting struggling software names. Despite AI disruption fears and Middle East tensions pressuring growth stocks, the strategy's quality-focused approach and early-cycle industrial positioning delivered relative outperformance. |
| Jan 7 2026 | 2025 Q4 | ACN, ADBE, ANET, AVGO, CMG, DDOG, EQIX, ETN, GOOGL, ISRG, LLY, MRVL, NVDA, ORCL, PLTR, SBUX, TMO, UNH, VRTX, WDAY | AI, growth, healthcare, large cap, momentum, semiconductors, technology, underperformance | - | ClearBridge Large Cap Growth underperformed by 900bps in 2025 due to underweights in mega cap AI names despite correctly owning Nvidia since 2018. Managers acknowledge underestimating AI spending magnitude but believe current momentum-driven market is unsustainable. Actively repositioning for broader participation as economy ex-tech accelerates from fiscal stimulus and monetary easing. |
| Oct 1 2025 | 2025 Q3 | AAPL, ACN, AIR.PA, AVGO, CMG, COST, CRM, DDOG, FICO, GOOGL, INTU, ISRG, LLY, MA, MSFT, NFLX, NSC, NVO, ORCL, PH, PLTR, RTX, SBUX, TSM, UNH, UNP, VRTX, WDAY, ZTS | AI, Cloud, cyclicals, growth, healthcare, large cap, technology |
ORCL US DDOG US VRTX US |
ClearBridge Large Cap Growth underperformed in Q3 due to AI winner/loser divergence but actively repositioned by upgrading to infrastructure software leaders Oracle and Datadog, exiting healthcare amid sector headwinds, and adding early cyclical exposure. Managers maintain disciplined valuation focus and three-bucket growth framework while expressing cautious optimism for 2026 across multiple scenarios. |
| Jul 29 2025 | 2025 Q2 | AAPL, ADBE, AIR.PA, AVGO, ETN, GWW, ICLR, LIN, LLY, META, MMC, MRVL, MSFT, NFLX, NOW, NVDA, TGT, TMO, TSM, UNH, V | AI, diversification, growth, large cap, positioning, risk management, semiconductors, technology |
TSM MRVL NOW AIR FP LIN ICLR |
ClearBridge Large Cap Growth underperformed in Q2 2025 as their diversified approach faced headwinds from concentrated mega-cap technology leadership. The team actively repositioned, broadening AI semiconductor exposure through Broadcom and Marvell while adding international diversification via Airbus and Linde. Despite near-term challenges, they remain committed to balanced, risk-aware growth investing. |
| Apr 8 2025 | 2025 Q1 | AAPL, ALC, AMZN, GOOGL, ICE, INTU, META, MMC, MNST, MSFT, NVDA, RTX, SBUX, SHW, SNPS, SPGI, TSLA, UBER, V | AI, growth, large cap, Magnificent Seven, semiconductors, tariffs, technology | - | ClearBridge Large Cap Growth outperformed during Q1 correction by underweighting Magnificent Seven and maintaining diversified stock selection. The Strategy has lower tariff exposure than benchmark and is positioned for earnings growth broadening beyond mega caps to industrials and health care companies through better margins and earnings inflection. |
| Jan 7 2025 | 2024 Q4 | ABNB, ACN, AMZN, ASML, AVGO, GOOGL, ISRG, LLY, META, NEE, NFLX, NVDA, NVO, TMO, TSLA, UBER, UNH, V, ZTS | growth, healthcare, large cap, Magnificent Seven, technology, Valuations |
ICLR NVO ABNB |
ClearBridge's diversified large cap growth strategy underperformed momentum-driven markets in Q4 but used dislocations to add healthcare and consumer discretionary exposure through new positions in Novo Nordisk and Airbnb. Managers positioned defensively for potential turbulence from elevated valuations and Trump policy uncertainty while seeing opportunities outside Magnificent Seven stocks. |
| Sep 30 2024 | 2024 Q3 | AAPL, ACN, AMZN, APTV, CMG, EL, EQIX, GOOGL, META, MMC, MSFT, NEE, NVDA, PYPL, RTX, SBUX, SHW, TEAM, TSLA, UNH | AI, diversification, growth, healthcare, large cap, technology, valuation |
SBUX EL TEAM APTV |
ClearBridge's Large Cap Growth Strategy outperformed through diversified positioning across stable, cyclical, and growth companies. Managers added Starbucks and Accenture at attractive valuations while exiting underperformers. Portfolio balances selective mega-cap exposure with defensive names for downside protection. Strategy positioned for multiple scenarios with cyclical exposure for growth and stable names for economic slowdowns. |
| Jun 30 2024 | 2024 Q2 | AAPL, ADBE, AMZN, ASML, ETN, GOOGL, META, MSFT, NFLX, NVDA, PANW, PYPL, TEAM, TGT, TSLA, UNH, UNP, WDAY, ZTS | AI, growth, large cap, Mega Cap, risk management, semiconductors, technology | - | ClearBridge outperformed through active mega cap management and early-cycle stock selection, maintaining 35.7% Magnificent Seven exposure versus benchmark's 48%. Risk management drives positioning with trimming from expensive growth names into undervalued stable and cyclical companies. Preparing for multiple economic scenarios through diversified growth bucket positioning while targeting industrials, retailers, and free cash flow supported names. |
| Apr 20 2024 | 2024 Q1 | AAPL, ADBE, AMZN, ASML, ETN, GOOGL, META, MSFT, NFLX, NVDA, PANW, PYPL, TEAM, TGT, TSLA, UNH, UNP, WDAY, ZTS | AI, cyclicals, growth, large cap, risk management, semiconductors, technology | - | ClearBridge's Large Cap Growth Strategy outperformed through active mega cap management and early-cycle positioning. Managers are trimming expensive growth names while adding to undervalued cyclicals, preparing for economic soft landing scenarios. Strategy maintains disciplined exposure to Magnificent Seven at 36% versus 48% benchmark weight, enabling diversification into quality industrials and stable growth companies with strong cash flows. |
| Mar 1 2024 | 2023 Q4 | AAPL, AMZN, APTV, CSCO, DXCM, EL, GOOGL, ICE, META, MSFT, NFLX, NKE, NVDA, SPLK, SYK, TGT, TMO, TSLA, U, UNP, UPS | AI, diversification, growth, large cap, Magnificent Seven, technology | - | ClearBridge's diversified large cap growth strategy outperformed through active management of Magnificent Seven exposure and tactical bucket allocation shifts. The team opportunistically trimmed Nvidia while adding cyclical positions like Target and Estee Lauder. Despite expecting macro deceleration and volatility, they're positioned for broadening market participation with focus on cash-generative growth companies where estimates have reset. |
| Nov 10 2023 | 2023 Q3 | ADBE, AMZN, CSCO, DXCM, EL, ETN, GWW, INTU, ISRG, LLY, NKE, NVDA, SE, SPLK, TEAM, TGT, UBER, UNH, UNP, V | AI, China, consumer, growth, healthcare, large cap, technology | - | ClearBridge's Large Cap Growth Strategy underperformed in Q3 due to healthcare GLP-1 risks and China consumer weakness, but strong tech selection provided offsets. Managers trimmed healthcare overweights while adding earnings reset names Target and Union Pacific. Portfolio positioned for soft landing scenario emphasizing organic growth companies and AI secular themes with stable growers and recovering enterprise software. |
| Jun 30 2023 | 2023 Q2 | AAPL, ADBE, ALC, AMZN, EL, ETN, INTU, ISRG, LLY, META, MSFT, NFLX, NKE, NVDA, PYPL, SE, SYK, TMO, UBER | AI, growth, large cap, Medical Devices, semiconductors, stock selection, technology |
AAPL|MSFT|NFLX|NVDA|UNH INTU |
ClearBridge's Large Cap Growth Strategy delivered its third consecutive quarter of outperformance through improved stock selection, particularly in AI-beneficiary Nvidia and recovering names like Meta and Netflix. The managers are tactically reducing their technology underweight while targeting quality consumer names with de-risked estimates, maintaining a diversified growth approach despite narrow market leadership. |
| Mar 31 2023 | 2023 Q1 | LLY, MSFT, NEE, NVDA | - | - |
| QUARTER | THEMES | TAGS |
|---|---|---|
| 2026 Q1 |
AIGrowth stocks were pressured as investors questioned the return on investment from massive capital spending on AI buildouts. Software companies were impacted by fears of disintermediation by AI, with generative AI tools introduced during the quarter affecting application software business models. |
Artificial Intelligence Software Generative AI Technology Disruption |
SemiconductorsThe managers remain optimistic on semiconductor trends and added Texas Instruments, focused on analog semiconductor devices. They view the company as well positioned for improving manufacturing outlook with 30-40% of its customer base in industrials. |
Analog Semiconductors Manufacturing Industrials Cyclical Recovery | |
BiotechnologyAdded two new biotech positions in Roche and Alnylam Pharmaceuticals to improve quality of healthcare holdings. Roche has attractive growth runway with multiple positive Phase III readouts, while Alnylam pioneered RNAi drugs and reached free cash flow breakeven. |
RNAi Phase III Free Cash Flow Pipeline Cardiomyopathy | |
DefenseDefense contractor RTX was a solid contributor during the volatile quarter, benefiting from increased market dispersion away from technology and momentum stocks that previously led the market. |
Defense Contractor Geopolitical Diversification Risk-off Stability | |
| 2025 Q4 |
AIThe Strategy significantly underperformed due to underweights to mega cap AI beneficiaries and lower-quality AI-related names. Managers acknowledge underestimating the magnitude of AI spending growth in 2025 and were active in upgrading AI participation through purchases of Broadcom, Marvell Technology, Datadog and Oracle. They view AI as the most transformative technology of their careers but expect volatility as the trend evolves. |
Artificial Intelligence Generative AI AI Spending AI Infrastructure AI Applications |
SemiconductorsNvidia was one of the top portfolio holdings and a positive contributor, purchased in 2018. Broadcom shares rose more than 40% but was a relative detractor due to underweight positioning. The managers see continued opportunity in custom silicon chips for AI workloads and networking equipment critical to cloud platforms. |
Nvidia Broadcom Custom Silicon AI Chips Semiconductor Equipment | |
CloudThe pace of capex increases by cloud hyperscalers surprised managers most about 2025's surge. They see Arista Networks as well-positioned among hyperscalers to benefit from the capex cycle. Oracle represents a highly levered opportunity in cloud business despite current market skepticism about AI capex leading to revenue and profitability. |
Hyperscalers Cloud Infrastructure Data Centers Oracle Arista Networks | |
MomentumThe Strategy's relative overweight to quality and underweight to momentum factors negatively affected results in 2025. Wide dispersion emerged between momentum stocks and quality stocks, particularly in the second half. The current growth market is momentum oriented and sentiment driven, which managers view as not durable. |
Momentum Stocks Quality Factor Market Leadership Sentiment Driven Growth Market | |
| 2025 Q3 |
AIThe growth market has seen wide divergence between AI winners and AI losers since Liberation Day, with AI winners including cloud providers, chip makers and infrastructure software companies rallying strongly while capital flows out of perceived AI laggards in application software and services. The managers are adding new AI-indexed growth ideas in a disciplined way rather than chasing momentum. |
Cloud Semiconductors Enterprise Software Data Centers Infrastructure |
CloudOracle has successfully expanded into cloud infrastructure as a platform to run generative AI workloads and is gaining share among hyperscalers due to its lower-cost data center architecture. Datadog operates a monitoring platform for cloud applications with observability being a large and growing end market as application complexity grows. |
Data Centers Infrastructure Observability Enterprise Software | |
| 2025 Q2 |
AIThe Strategy broadened AI semiconductor exposure through new positions in Broadcom and Marvell Technology. Broadcom enables better participation in custom silicon chips for AI computing, working with large technology companies to develop custom silicon alongside Nvidia's GPUs. Marvell designs chips and networking equipment for AI, cloud computing and 5G infrastructure with strong interconnect business. |
Semiconductors Custom Silicon GPUs Networking Computing |
SemiconductorsThe Strategy actively repositioned semiconductor holdings, trimming Taiwan Semiconductor due to geopolitical tensions and adding Broadcom and Marvell Technology. Focus on companies designing chips for AI computing and networking equipment. Marvell's valuation has compressed significantly, trading at a discount to AI semiconductor peers despite high-quality asset portfolio. |
AI Custom Silicon Networking Foundries Valuation | |
CloudServiceNow was added as a new position, providing end-to-end software-as-a-service platform to help enterprise customers automate business processes. The company has a monetizable generative AI product being adopted by customers. Broadcom's cloud infrastructure software business is expected to continue growing given its entrenched position within enterprises. |
SaaS Enterprise Software Automation Infrastructure AI | |
DefenseAirbus was added as a new position, with its defense segment expected to benefit from EU ramping up defense spending as the US pulls back on overseas security commitments. The company designs and manufactures defense systems alongside commercial aircraft and aerospace components. |
Defense Spending EU Aerospace Security Manufacturing | |
| 2025 Q1 |
AIThe emergence of DeepSeek, a Chinese large language model with capabilities similar to the best LLMs but built with inferior chips and at lower cost, caused investors to question whether massive capex devoted to Gen AI would continue. Nvidia fell sharply despite delivering record financial results amid strong rollout for its newest Blackwell GPU system. |
Artificial Intelligence LLM GPU Capex DeepSeek |
Trade PolicyTrump's actions to reorder global trade dominated headlines with 25% steel and aluminum tariffs, additional 20% tariff on China, plus 25% tariffs on most goods from Canada and Mexico. The Strategy has lower tariff exposure than benchmark with portfolio companies sourcing close to 8% revenue from China versus 10% for the index. |
Tariffs China Trade Revenue Exposure | |
SemiconductorsThe purchase of Synopsys, a leader in electronic design automation software and custom chip designs, represents positioning for AI infrastructure spending and increasingly complex chip design. The company operates in a duopoly market with multiple growth avenues driven by increased semiconductor chip complexity. |
EDA Chip Design Software Duopoly Infrastructure | |
| 2024 Q4 |
AIAI is clearly a megatrend that the managers are monitoring closely to gauge the next phase of use cases and impact both to technology-oriented businesses and to those in more traditional industries. Portfolio holding Intuitive Surgical is making significant strides in providing feedback to surgeons using its robotic instruments. |
Artificial Intelligence Robotics Innovation Technology Automation |
GLP1The managers established a position in Novo Nordisk, a leader in diabetes and obesity treatments, following disappointing clinical trial results. They believe Novo's enhanced CagriSema weight loss treatment is a more potent formulation that can better compete with Eli Lilly's suite, given the large secular growth trends behind the diabesity market. |
Obesity Diabetes Weight Loss Pharmaceuticals Healthcare | |
TravelThe managers reduced their consumer discretionary underweight by purchasing Airbnb, noting that travel in aggregate is an attractive end market with Airbnb's alternative accommodations segment gaining share in the industry. Following a period of slowing travel demand, which they view as largely cyclical, they believe the stock offers attractive risk-reward for a high-quality, stable growth business. |
Lodging Tourism Marketplace Cyclical Recovery | |
| 2024 Q3 |
AIThe Strategy manages exposure to AI-driven growth stocks including NVIDIA, which has been trimmed due to valuation concerns despite belief in its 10-year trajectory as hyperscaler and enterprise customers invest in GPU architecture. The managers acknowledge AI momentum has driven market leadership but are selective about valuations. |
GPU Hyperscaler Enterprise Architecture Growth |
GrowthThe Strategy focuses on companies capable of generating organic growth through a slowing economy, emphasizing diversification across stable, cyclical, and higher-growth buckets. Performance is driven by broader participation among growth holdings in health care, communication services and industrials. |
Organic Diversification Stable Cyclical Participation | |
ValueThe managers emphasize being sensitive to valuation as core to portfolio construction, taking advantage of volatility to initiate positions at attractive entry points. They remain disciplined around entry points and focus on attractive risk-reward opportunities. |
Valuation Entry Volatility Risk-reward Disciplined | |
| 2024 Q2 |
AIContinued enthusiasm for generative artificial intelligence boosted market performance, with mega cap growth stocks maintaining leadership. The Strategy maintains exposure to AI beneficiaries including Nvidia, which was a leading contributor to performance. |
Artificial Intelligence Generative AI Technology Nvidia Growth |
SemiconductorsThe Philadelphia Semiconductor Index saw significant gains in 2023, and the managers expect early cyclical recovery in semiconductors as the economy potentially moves past a slowdown. ASML and other semiconductor equipment makers are positioned for this cycle. |
Semiconductor Cycle ASML Equipment Cyclical Recovery | |
Risk ManagementRisk management has guided recent positioning activity, with trimming from select growth companies and redeploying into undervalued stable and cyclical names. The managers are preparing for a range of economic outcomes through diversification across growth buckets. |
Risk Management Diversification Positioning Trimming Redeployment | |
| 2024 Q1 |
AIContinued enthusiasm for generative artificial intelligence boosted market performance, with mega cap growth stocks maintaining leadership. The Strategy maintains exposure to AI beneficiaries while managing concentration risk. |
Artificial Intelligence Generative AI Technology Mega Cap Growth |
SemiconductorsThe Philadelphia Semiconductor Index saw significant gains in 2023, and the managers expect early cyclical recovery in semiconductors as the economy potentially moves past a slowdown. ASML and Nvidia are key holdings. |
Semiconductor Cycle Early Cyclical Equipment Recovery Chips | |
Risk ManagementRisk management has guided recent positioning activity, with trimming from select growth companies and redeploying into undervalued stable and cyclical names to prepare for varying market conditions. |
Position Sizing Diversification Trimming Redeployment Active Management | |
| 2023 Q4 |
AIMicrosoft and Nvidia continued to be supported by strong execution and leadership positions in the implementation of generative artificial intelligence. AI will remain a key trend supporting parts of technology going forward. |
Generative AI Technology Microsoft Nvidia Implementation |
GrowthThe strategy maintains diversified exposure across three buckets of growth: select, stable and cyclical. Portfolio positioning shifted tactically throughout the year to best position for a slowing growth environment, with 57% in stable bucket, 31% in select and 11% in cyclical at quarter end. |
Diversified Growth Select Growth Stable Growth Cyclical Growth Portfolio Construction | |
E-commerceAmazon benefited from strong margin expansion across segments, most notably its core e-commerce business. The strategy maintains overweight exposure to Amazon as one of the Magnificent Seven holdings. |
Amazon Margin Expansion Core Business Overweight | |
| 2023 Q3 |
AIPortfolio includes companies directly indexed to the secular growth of artificial intelligence. Research efforts focus on new use cases as inference models ramp up and determining which software and services companies will remain relevant versus being supplanted by AI. |
Artificial Intelligence Inference Models Software Services Secular Growth |
GLP1Positive clinical trials showing cardiovascular benefits for GLP-1 diabetes and obesity therapeutic semaglutide boosted Eli Lilly shares. However, this raised risks for DexCom and Intuitive Surgical due to potential lower utilization from improved patient outcomes. |
Diabetes Obesity Cardiovascular Medical Devices Therapeutics | |
ChinaConsumer weakness in China affected Nike and Estee Lauder performance during the quarter. The world's second largest economy continues to be held back by a tepid COVID-19 recovery and weakness in its sprawling property sector. |
Consumer Recovery Property Economy Demand | |
| 2023 Q2 |
AIGenerative AI enthusiasm drove mega cap performance with Nvidia as a key beneficiary. The manager views AI as transforming from a perceived risk into an opportunity, with companies like Adobe moving quickly into generative AI and license protection. |
Generative AI GPUs Data Centers Training Inference |
SemiconductorsNvidia exemplifies the semiconductor opportunity, with the manager building the position since 2018 based on GPU potential for complex computing problems. Despite expensive current valuation, long-term runway remains compelling due to advantaged positioning in large addressable GPU market. |
GPUs Data Center Gaming Chip Design | |
Medical DevicesImproved procedure growth benefiting medical device stocks as supply chain headwinds and labor shortage bottlenecks ease. Ambulatory surgery centers adding more hours should boost companies like Intuitive Surgical, Alcon, and Stryker. |
Surgery Procedures Medical Equipment Healthcare |
| Date | Pitch Type | Author | Ticker | Company | Industry | Sub Industry | Bull / Bear | Exchange | Keywords | Action |
|---|---|---|---|---|---|---|---|---|---|---|
| Apr 8, 2026 | Fund Letters | ClearBridge Investments Large Cap Growth Strategy | TXN | Texas Instruments | Semiconductors | Semiconductors & Semiconductor Equipment | Bull | NASDAQ | Analog, Cyclical, Embedded Processing, Free Cash Flow, Industrials, manufacturing, semiconductors | Login |
| Apr 8, 2026 | Fund Letters | ClearBridge Investments Large Cap Growth Strategy | ROG.SW | Roche | Drug Manufacturers - General | Pharmaceuticals | Bull | Swiss Exchange | multiple sclerosis, Oncology, Patent Expiry, pharmaceuticals, Phase III, pipeline, Revenue Growth | Login |
| Apr 8, 2026 | Fund Letters | ClearBridge Investments Large Cap Growth Strategy | ALNY | Alnylam Pharmaceuticals | Biotechnology | Biotechnology | Bull | NASDAQ | biotechnology, Cardiomyopathy, Free Cash Flow, pipeline, Protein Silencing, Rnai, valuation | Login |
| Apr 8, 2026 | Fund Letters | ClearBridge Investments Large Cap Growth Strategy | CRM | Salesforce | Software - Application | Software | Bear | New York Stock Exchange | cloud, Competition, CRM, growth deceleration, Pricing Model, SaaS, Software | Login |
| Apr 8, 2026 | Fund Letters | ClearBridge Investments Large Cap Growth Strategy | PYPL | PayPal | Credit Services | IT Services | Bear | NASDAQ | business transformation, digital payments, Fintech, Opportunity-Cost, turnaround | Login |
| Oct 1, 2025 | Fund Letters | Peter Bourbeau | ORCL US | Oracle Corp. | Information Technology | Systems Software | Bull | NYSE | AI, cloud, FCF, growth, infrastructure, Margins, Software, valuation | Login |
| Oct 1, 2025 | Fund Letters | Peter Bourbeau | DDOG US | Datadog, Inc. | Information Technology | Application Software | Bull | NASDAQ | AI, cloud, growth, innovation, Margins, observability, SaaS | Login |
| Oct 1, 2025 | Fund Letters | Peter Bourbeau | VRTX US | Vertex Pharmaceuticals Inc. | Health Care | Biotechnology | Bull | NASDAQ | Biotech, cash, Cystic fibrosis, growth, Pain, pipeline, R&D, valuation | Login |
| Jul 29, 2025 | Fund Letters | Peter Bourbeau | TSM | Taiwan Semiconductor Manufacturing Company Limited | Information Technology | Semiconductors | Bear | NYSE | CapEx, Concentration, Geopolitics, Risk, semiconductors | Login |
| Jul 29, 2025 | Fund Letters | Peter Bourbeau | MRVL | Marvell Technology, Inc. | Information Technology | Semiconductors | Bull | NASDAQ | AI, Interconnect, Networking, semiconductors, valuation | Login |
| Jul 29, 2025 | Fund Letters | Peter Bourbeau | NOW | ServiceNow, Inc. | Information Technology | Systems Software | Bull | NYSE | AI, Automation, Margins, SaaS, Workflows | Login |
| Jul 29, 2025 | Fund Letters | Peter Bourbeau | AIR FP | Airbus SE | Industrials | Aerospace & Defense | Bull | Euronext Stock Exchange | Aerospace, backlog, cashflow, Defense, Travel | Login |
| Jul 29, 2025 | Fund Letters | Peter Bourbeau | LIN | Linde plc | Materials | Industrial Gases | Bull | NYSE | cashflow, Gases, Industrial, Pricing, Space | Login |
| Jul 29, 2025 | Fund Letters | Peter Bourbeau | ICLR | ICON plc | Health Care | Life Sciences Tools & Services | Bear | NASDAQ | Funding, Normalization, Outsourcing, Pipelines, visibility | Login |
| Dec 31, 2024 | Fund Letters | ClearBridge Investments Large Cap Growth Strategy | ICLR | ICON plc | Health Care | Life Sciences Tools & Services | Bull | NASDAQ | Biotech, Clinical trials, contract research, Cro, Cyclical Recovery, healthcare, Pharmaceutical Services, Value | Login |
| Dec 31, 2024 | Fund Letters | ClearBridge Investments Large Cap Growth Strategy | NVO | Novo Nordisk A/S | Health Care | Pharmaceuticals | Bull | NYSE | Danish, Diabetes, GLP-1, Obesity, pharmaceuticals, secular growth, semaglutide, Weight loss | Login |
| Dec 31, 2024 | Fund Letters | ClearBridge Investments Large Cap Growth Strategy | ABNB | Airbnb, Inc. | Consumer Discretionary | Hotels, Restaurants & Leisure | Bull | NASDAQ | Alternative Accommodations, Consumer Discretionary, Cyclical, high margins, Lodging, marketplace, Peer-to-Peer, Travel | Login |
| Sep 30, 2024 | Fund Letters | ClearBridge Investments Large Cap Growth Strategy | SBUX | Starbucks Corporation | Consumer Discretionary | Restaurants | Bull | NASDAQ | brand value, CEO change, Coffee Retailer, Consumer Discretionary, Global Retail, Operational Improvement, turnaround | Login |
| Sep 30, 2024 | Fund Letters | ClearBridge Investments Large Cap Growth Strategy | EL | The Estée Lauder Companies Inc. | Consumer Staples | Personal Products | Bear | NYSE | China exposure, consumer staples, Cosmetics, exit strategy, Skincare, Travel Retail, Turnaround Failure | Login |
| Sep 30, 2024 | Fund Letters | ClearBridge Investments Large Cap Growth Strategy | TEAM | Atlassian Corporation | Information Technology | Software | Bear | NASDAQ | cloud migration, collaboration software, Enterprise software, Headcount Rationalization, IT Budget Pressure, Seat-Based Model | Login |
| Sep 30, 2024 | Fund Letters | ClearBridge Investments Large Cap Growth Strategy | APTV | Aptiv PLC | Consumer Discretionary | Automobile Components | Bear | NYSE | Auto Components, Automotive Supplier, Electric Vehicles, Ev-Transition, Global Auto Demand, multiple expansion, Tier 1 Supplier | Login |
| Jun 30, 2023 | Fund Letters | ClearBridge Investments Large Cap Growth Strategy | AAPL|MSFT|NFLX|NVDA|UNH | Nvidia Corporation | Information Technology | Semiconductors & Semiconductor Equipment | Bull | NASDAQ | Artificial Intelligence, data center, Gaming, generative AI, Gpu, growth, Pricing power, semiconductors | Login |
| Jun 30, 2023 | Fund Letters | ClearBridge Investments Large Cap Growth Strategy | INTU | Intuit Inc. | Information Technology | Software | Bull | NASDAQ | Accounting, ARPU growth, SaaS, small business, Software, TAM expansion, tax preparation | Login |
| TICKER | COMMENTARY |
|---|---|
| LIN | Materials was the largest contributor to relative performance in the quarter as industrial gases provider Linde and paint and coatings maker Sherwin-Williams were solid performers in an environment that has begun to reward companies with quality fundamentals. |
| SHW | Materials was the largest contributor to relative performance in the quarter as industrial gases provider Linde and paint and coatings maker Sherwin-Williams were solid performers in an environment that has begun to reward companies with quality fundamentals. |
| ETN | The Strategy also saw contributions from a diversified mix of industrials names, led by Eaton, a key provider of equipment to enable electrical connectivity. |
| GWW | The Strategy also saw contributions from a diversified mix of industrials names, led by Eaton, a key provider of equipment to enable electrical connectivity; W.W. Grainger, a distributor of industrial supplies. |
| RTX | The Strategy also saw contributions from a diversified mix of industrials names, led by Eaton, a key provider of equipment to enable electrical connectivity; W.W. Grainger, a distributor of industrial supplies; and RTX, a defense contractor. |
| NFLX | We were also encouraged by the rebound in Netflix after the streaming provider withdrew from a bidding war for Warner Bros. Discovery; we believe the fundamental setup for its business remains robust. |
| INTU | These holdings helped offset weakness among the portfolio's software names. Tax prep software maker Intuit, credit score provider Fair Isaac, cloud hyperscaler Oracle and enterprise software firm Salesforce were all impacted by a broad acceleration in the selloff among software companies feared to be disintermediated by AI. |
| FICO | Fair Isaac, known for its FICO score, was also hurt by concerns about growing competition that we believe are overblown as the company continues to deliver considerable value to its customers. |
| ORCL | These holdings helped offset weakness among the portfolio's software names. Tax prep software maker Intuit, credit score provider Fair Isaac, cloud hyperscaler Oracle and enterprise software firm Salesforce were all impacted by a broad acceleration in the selloff among software companies feared to be disintermediated by AI. |
| CRM | We completed an exit from Salesforce this quarter after trimming the position as part of our actions to reduce software exposure over the past year. Since 2022, Salesforce has experienced slowing growth in its core business across its sales and service cloud segments and, more recently, marketing cloud. While Salesforce is executing on several product strategies to accelerate growth, we think these initiatives are not substantial enough to bend the curve on overall revenue growth. |
| TXN | We continue to be optimistic on trends in the semiconductor sector and added a new position during the quarter in Texas Instruments, a company focused on analog semiconductor devices and embedded processing. The company sells products with long life cycles to a diversified customer base and has a unique free cash flow story. |
| RHHBY | We also added two new positions in the health care sector with the additions of Roche and Alnylam Pharmaceuticals. We believe Roche has an attractive growth runway with multiple positive Phase III readouts in early-stage breast cancer and multiple sclerosis. |
| ALNY | Alnylam has pioneered RNAi drugs that work to silence certain proteins created by the body that can malfunction and cause disease. The company's key product, Amvuttra, treats a condition that leads to protein misfolding in the heart and, eventually, heart failure. Alnylam also reached free cash flow breakeven in 2025, a milestone that we seek in biotech investments to derisk some downside potential. |
| PYPL | We exited PayPal and Equinix during the quarter. When we invest in businesses like PayPal executing upon turnarounds, we regularly weigh the positive outcome of improved execution with downside risks, including the opportunity cost of longer than expected paths to improvement. While there are some signs of improvement in PayPal's business, the turnaround has proved more challenging than expected, leading us to exit the position. |
| EQIX | Equinix owns and operates interconnected data centers that provide network and cloud platforms for enterprise customers. The stock was sold as the company remains in the middle of a large capex investment cycle while AI tailwinds from increased customer spending on inference will take time to show through. |
| ASML | On an individual stock basis, the leading contributors to relative performance included ASML, Taiwan Semiconductor, Eaton, Netflix and an underweight to Microsoft. |
| TSM | On an individual stock basis, the leading contributors to relative performance included ASML, Taiwan Semiconductor, Eaton, Netflix and an underweight to Microsoft. |
| MSFT | On an individual stock basis, the leading contributors to relative performance included ASML, Taiwan Semiconductor, Eaton, Netflix and an underweight to Microsoft. |
| BX | In addition to the transactions mentioned above, we initiated a position in Blackstone in the financials sector. |
| Ticker | Put/Call | Amount Bought | Shares Bought | % Change | Weight % |
|---|---|---|---|---|---|
| No Recent Buys Data | |||||
| Ticker | Put/Call | Amount Sold | Shares Sold | % Change | Weight % | Status |
|---|---|---|---|---|---|---|
| No Recent Sells Data | ||||||
| Industry | Prev Quarter % | Current Quarter % | Change |
|---|---|---|---|
| No industry data available | |||